SCHEMBL4845633

SCHEMBL4845633

COC(=O)Cc1ccc(OCCN)cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.49
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
MAOB P27338 3/20 0.39
PARP14 Q460N5 1/20 0.39
PARP10 Q53GL7 1/20 0.39
NR1H3 Q13133 1/20 0.39
P2RX7 Q99572 1/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
AOC3 Q16853 1/20 0.38
PDE10A Q9Y233 1/20 0.38
FFAR1 O14842 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19025299 0.87 KDM1A (0.48) KDM1AMTNR1AMTNR1BMAOBPARP14
SCHEMBL30581848 0.87 KDM1A (0.48) KDM1AMTNR1AMTNR1BMAOBPARP14
SCHEMBL25379572 0.87 KDM1A (0.51) KDM1AMTNR1AMTNR1BMAOBNR1H3
SCHEMBL4841319 0.86 MTNR1A (0.41) KDM1AMTNR1AMTNR1BALDH1A1KDM4E
SCHEMBL1922899 0.83 KDM4E (0.52) KDM1AMAOBP2RX7ALDH1A1KDM4E
SCHEMBL31263830 0.83 KDM4E (0.52) KDM1AMAOBP2RX7ALDH1A1KDM4E
SCHEMBL25380377 0.80 KDM1A (0.62) KDM1AALDH1A1KDM4EHPGDRAB9A
SCHEMBL19618908 0.80 TAAR1 (0.42) MAOBSMN1; SMN2AOC3
SCHEMBL29593701 0.80 MAOB (0.50) KDM1AMAOBALDH1A1RAB9ASMN1; SMN2
SCHEMBL31045754 0.79 KDM4E (0.44) KDM1AP2RX7ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102746214-A Novel indoline compounds FOURNIER LAB SA 2012-10-24 CN disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
CN-101184731-A Indoline compounds FOURNIER LAB SA (FR) 2008-05-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 KDM1A 1115/4885MTNR1A 47/4885MTNR1B 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.